Ventricular Assist Devices: Market Research Report

February 2009 | 168 pages | ID: V5AEC1D8D67EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Ventricular Assist Devices in Millions of US$.

The report provides separate comprehensive analytics for the US, Europe, and Rest of World.

Annual forecasts are provided for the period of 2006 through 2015.

A five-year historic analysis is also provided for these markets with annual market analytics.

The report profiles 28 companies including many key and niche players worldwide such as Abiomed, Inc., Berlin Heart GmbH, EvaHeart Medical USA, Inc., HeartWare Limited, Jarvik Heart, Inc., MEDOS Medizentechnik AG, MicroMed Cardiovascular, Inc., SynCardia Systems, Inc., Terumo Heart, Inc., Thoratec Corporation, Ventracor Limited, and World Heart Corporation.

Market data and analytics are derived from primary and secondary research.

Company profiles are mostly extracted from URL research and reported select online sources.

Contents

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INTRODUCTION

Global & Regional Market Analysis
Opportunities in VAD Market
Destination Therapy – An Immense Potential Opportunity
Next Generation Devices to Offer Pronounced Scope
Heart Transplantation Scenario

Table 1. Number of Heart Transplants Worldwide (2000-2006) (In Units) (includes corresponding Graph/Chart)

Table 2. Heart Transplants Worldwide (2008E): Percentage Share Breakdown by Country/Region (includes corresponding Graph/Chart)

2. COMPETITION

Thoratec is the Clear Leader
Leading Players in the Global VAD Market

Table 3. Leading Players in the Global VAD and Circulatory Support Market (2007): Percentage Breakdown of Value Sales for Thoratec, Abiomed, WorldHeart and Others (includes corresponding Graph/Chart)

Table 4. Global VAD Market (2007): Implantations in Units by Select Player – Thoratec, MicroMed Cardiovascular, Berlin Heart, Ventracor, Terumo Heart and HeartWare (includes corresponding Graph/Chart)

Competition Heats Up
Competitive Technologies

3. VAD – AN INSIGHT

Heart – The Vital Organ
Heart Diseases
Congenital Heart Disease
Congestive Heart Failure
Mechanical Circulatory Support Systems
Total Artificial Heart
VADs
VADs Usage by Indication and Time Duration
Types
VAD Components
VAD Pumps
Li-Ion Batteries: Reliable Power Sources for Portable Medical Devices
Implantation Procedure
Aftercare
Complications
Infection
Internal Bleeding
Thrombus

Table 5. Percentage Breakdown of Possible Complications in VADs Usage by Type – Infection, Bleeding, Arrhythmia, Renal Dysfunction, Respiratory Dysfunction, Neurologic Dysfunction, RV Dysfunction and Others (includes corresponding Graph/Chart)

Pricing of VAD

Table 6. Average Selling Prices of Select VADs by Company and Model

VAD Improvisations
LVADs – An Introduction
LVAD Milestones
An Effective Therapeutic Device for End-Stage Congestive Heart Failure
Ventricular Assistance Vs. Heart Replacement

4. AN INSIGHT INTO THE FIRST, SECOND AND THIRD GENERATION VADS

First Generation VAD
Second Generation VAD
Rotary Axial Flow Pumps
Drawbacks of Axial Flow Pump
Third Generation VAD
Select First, Second and Third Generation Implantable VADs

5. REIMBURSEMENT SCENARIO

Government Regulations
The US
Canada
Europe

6. PRODUCT APPROVALS/INNOVATIONS/INTRODUCTIONS

Thoratec Receives FDA Approval for its HeartMate II LVAS
HeartWare Receives Conditional Approval for its HeartWare LVAS
Abiomed Receives CE Mark for AB5000 Portable Driver
Ventracor Receives USFDA Approval to Use its VentrAssist Device in Clinical Trials
NewCorTec Launches a New LVAD
WorldHeart Launches New Pediatric VAD
Ventracor Obtains FDA Approval for VentrAssist’s US BTT Trial
MicroMed Cardiovascular Obtains 5-Year CE Mark Extension for DeBakey
Thoratec Submits PMA for HeartMate II Left Ventricular Assist System
Ventracor Receives ‘Commercial Ready’ Grant to Develop VentrAssist LVAD
Terumo Heart Obtains CE Mark for its DuraHeart® LVAS in Europe
Abiomed Acquires Regulatory Approval in Australia for Impella LP 2.5 LVAD
Abiomed Receives FDA Approval for Impella 2.5 VAD Pilot Trials
Biophan Develops New MYO-VAD
Queensland University of Technology Invents Counter-Flow Pump
HeartWare Obtains German Regulatory Approval for its HVAD™
Abiomed Receives Regulatory Approval in France for its AB5000 VAD
MiTi Develops MitiHeart LVAD for Heart Failure Patients
MicroMed Cardiovascular’s ‘DeBakey VAD Child’ Receives FDA Approval

7.RECENT INDUSTRY ACTIVITY

UPMC Wins Gold Seal of Approval™ to Use VADs in Destination Therapy
E-Wilson Acquires 97% of the MicroMed Cardiovascular’s Outstanding Shares
World Heart Enters into Partnership with Abiomed
Thoratec Corporation Enters into Agreement with Levitronix
World Heart Implants First Rotary VAD
Abiomed Unveils a New Educational as well as Service Program
MicroMed Technology Merges with Salmon Express
Abiomed Acquires Impella CardioSystems
Thoratec Announces 40% Increase in Medicare Refund on VADs Used in DT
National Heart, Lung and Blood Institute Awards Contract worth $ 6.95 Million

8. FOCUS ON SELECT GLOBAL PLAYERS

Abiomed, Inc. (USA)
Berlin Heart GmbH (Germany)
EvaHeart Medical USA, Inc. (USA)
HeartWare Limited (Australia)
Jarvik Heart, Inc. (USA)
MEDOS Medizentechnik AG (Germany)
MicroMed Cardiovascular, Inc. (USA)
SynCardia Systems, Inc. (USA)
Terumo Heart, Inc. (USA)
Thoratec Corporation (USA)
Ventracor Limited (Australia)
World Heart Corporation (USA)

9. GLOBAL MARKET PERSPECTIVE

Table 7. World Recent Past, Current & Future Market Analysis for Ventricular Assist Devices by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 8. World Historic Review for Ventricular Assist Devices by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

Table 9. World 10-Year Perspective for Ventricular Assist Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. MARKET ANALYSIS

Heart Ailments – The Death Sentence

Table 10. Incidence, Prevalence and Deaths due to Heart Ailments in the US (2007) (includes corresponding Graph/Chart)

Huge Waiting Time for Heart Transplant
VADs for Heart Failures

Table 11. VAD Market in the US: Percentage Breakdown by Indication: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery and Others (includes corresponding Graph/Chart)

Market Dynamics
High Selling Price
Drug Industry Poses Intense Competition
Lack of Timely and Quick FDA Approvals
Reimbursement
CMS Increases LVAD Coverage for Heart Patients
New Facility Criteria to Hospitals on VAD Implantation for Destination Therapy
Competition

Table 12. Leading Players in the US Bridge-to-Transplant VAD Market (2008E) - Percentage Breakdown of Sales for Thoratec and Others

Table 13. Leading Players in the US destination therapy VAD Market (2007): Percentage Breakdown of Sales for Thoratec and Others

Product Approvals/Innovations/Introductions
Strategic Corporate Developments
Key Players

B. MARKET ANALYTICS

Table 14. US Recent Past, Current & Future Analysis for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 15. US Historic Review for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

2. EUROPE

A. MARKET ANALYSIS

Competitive landscape
Next-generation VADs in Europe by Company (2007)

Table 16. Heart Transplants and Patients Waiting List in Europe (2005-2007): Figures in Units (includes corresponding Graph/Chart)

Belgium
Reimbursement Scenario
Key Data

Table 17. Belgium VAD Market (2002-2005): Implants in Units (includes corresponding Graph/Chart)

Table 18. Belgium VAD Market (2002-2005): BTT Implants in Units (includes corresponding Graph/Chart)

Table 19. Belgium VAD Market (2004-2005): BTT Implants in Units by Device – Incor, Excor, Novacor, Thoratec, Medos, and TCI HM (includes corresponding Graph/Chart)

Germany
The United Kingdom
Product Approvals/Innovations/Introductions
Strategic Corporate Development
Key Players

B. MARKET ANALYTICS

Table 20. European Recent Past, Current & Future Analysis for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 21. European Historic Review for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

3. REST OF WORLD

A. MARKET ANALYSIS

Product Innovations/Approvals
Strategic Corporate Development
Key Players

B. MARKET ANALYTICS

Table 22. Rest of World Recent Past, Current & Future Analysis for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)

Table 23. Rest of World Historic Review for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE